Drug Shortage Report for MULTI-12/K1 PEDIATRIC

Last updated on 2023-05-30 History
Report ID 172557
Drug Identification Number 02242529
Brand name MULTI-12/K1 PEDIATRIC
Common or Proper name MULTI-12/K1 PED
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) VITAMIN D VITAMIN A ASCORBIC ACID VITAMIN B12 FOLIC ACID BIOTIN VITAMIN K1 VITAMIN E DEXPANTHENOL NICOTINAMIDE PYRIDOXINE HYDROCHLORIDE VITAMIN B2 VITAMIN B1
Strength(s) 400UNIT 2300UNIT 80MG 1MCG 140MCG 20MCG 0.2MG 7UNIT 5MG 17MG 1MG 1.4MG 1.2MG
Dosage form(s) LIQUID
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size SINGLE DOSE 10LIVI
ATC code B05XC
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-11-28
Estimated end date 2023-05-26
Actual end date 2023-05-19
Shortage status Resolved
Updated date 2023-05-30
Company comments Baxter item : 6461
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v25 2023-05-30 French Compare
v24 2023-05-30 English Compare
v23 2023-05-04 French Compare
v22 2023-05-04 English Compare
v21 2023-04-20 French Compare
v20 2023-04-20 English Compare
v19 2023-04-11 French Compare
v18 2023-04-11 English Compare
v17 2023-04-11 French Compare
v16 2023-04-11 English Compare
v15 2023-02-14 French Compare
v14 2023-02-14 English Compare
v13 2023-01-27 French Compare
v12 2023-01-27 English Compare
v11 2022-11-29 French Compare
v10 2022-11-29 English Compare
v9 2022-11-29 French Compare
v8 2022-11-29 English Compare
v7 2022-11-28 French Compare
v6 2022-11-28 English Compare

Showing 1 to 20 of 25